Stay updated on Lanadelumab for Pediatric HAE Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.

Latest updates to the Lanadelumab for Pediatric HAE Attacks Clinical Trial page
- Check6 days agoChange DetectedThe page history shows an added revision entry v3.3.2 and removal of v3.3.1, indicating a minor UI/version-labeling update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.1 on the page history.SummaryDifference0.1%

- Check20 days agoChange DetectedThe new screenshot removes a government funding/operating-status banner; the trial history content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check34 days agoChange DetectedThe new screenshot shows minor UI and layout updates to the Record History page, with no changes to the recorded version dates or study details, and the underlying history entries and their submission dates appear unchanged; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check70 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Lanadelumab for Pediatric HAE Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab for Pediatric HAE Attacks Clinical Trial page.